Summary
In an experimental study undertaken to elucidate the mechanism whereby Adriamycin (ADM) instilled into the bladder produces its side-effects, the time course of ADM concentration in blood, urine, and tissues of various organs, and also histopathological changes in the bladder mucosa were investigated in normal adult dogs that had undergone bilateral ureterostomy and then received intravesically instilled ADM. Clinically, ADM was used in the treatment of superficial bladder tumors in an attempt to facilitate the transurethral operative procedure. A total of 261 patients were included in this trial. ADM was instilled into the bladder at the following dosages: 1,000 μg/ml (30 mg ADM per 30 ml physiological saline), 1,600 μg/ml (50 mg ADM per 30 ml physiological saline), and 2,000 μg/ml (60 mg ADM per 30 ml physiological saline). The rate of effectiveness was 32%, 66%, and 60%, respectively. The incidence of side-effects was 29%, 20%, and 45%, respectively. The systemic uptake of the drug was small and the side-effects were pain an micturition, pollakiuria, and urgency. From the aspects of efficacy and toxicity, 1,600 μg/ml was found to be the optimal dosage.
Similar content being viewed by others
References
Abbassian A, Wallace DM (1966) Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder. J Urol 96:461
Esquivel EL Jr, Mackenzie AR, Whitmore WF Jr (1965) Treatment of bladder tumors by instillation of thio-TEPA, actinomycin D or 5-fluorouracil. Invest Urol 2:381
Imamura K, Yoshida H, Nakano H, Ikeuchi T, Yajima N, Shibaki K, Koshino Y, Saito T, Sagawa F, Namatame K (1974) Effects of intravesical treatment of bladder tumors with mitomycin C. Acta Urol Jpn 20:33
Jones HC, Swinney J (1961) Thio-TEPA in the treatment of tumors of the bladder. Lancet II:615
Kano M, Ito S (1973) The effect of intracavitary chemotherapy after transurethral resection on the recurrence rate of superficial bladder cancers. Jpn J Clin Urol 27:403
Mishina T, Oda K, Murata S, Ooe H, Mori Y, Takahashi T (1975) Mitomycin C bladder instillation therapy for bladder tumors. J Urol 114:217
Niijima T, Matsumura Y, Kondo K, Katayama Y, Ozaki Y (1975) Intravesical instillation of adriamycin for the treatment of tumor of the bladder: The preliminary report. Acta Urol Jpn 21:233
Nishiura T, Kumamoto E, Nishimura Y, Tawara M, Mizutani H, Kawada Y, Shimano E, Miyamura R, Takasaki E (1968) Effects of intravesical mitomycin C therapy in recurrent bladder tumors (preliminary report). Igaku no Ayumi 65:637
Ogawa H (1969) Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). (Report 1). Jpn J Urol 60:717
Ozaki Y (1977) Bladder instillation of adriamycin in the treatment of bladder tumors. 1. Clinical results. Jpn J Urol 68:934
Ozaki Y (1978) Bladder instillation of adriamycin in the treatment of bladder tumors. 2: Experimental study. Jpn J Urol 69:817
Shida K, Horaguchi T, Shinozaki T, Sato J, Takahashi H, Taya M, Kato N, Urano E, Ohkoshi M, Tazaki H, Ozeki T, Matsunaga J, Yajima T, Nagata M, Kitamura S, Kawai H, Ogawa H, Nakagami Y, Nakamura Y (1967) Treatment of bladder cancer with instillation of mitomycin C (first report). Jpn J Clin Urol 21:1057
Tomiyama T (1972) Effects of intravesical instillation of antitumor agents on bladder cancer. Jpn J Urol 63:497
Veenema RJ (1968) The role of thio-TEPA instillations in bladder cancer. JAMA 206:2725
Veenema RJ, Dean AL Jr, Roberts M, Fingerhut B, Chowhury BK, Tarassoly H (1962) Bladder carcinoma treated by direct instillations of thio-TEPA. J Urol 88:60
Veenema RJ, Dean AL Jr, Uson AC, Roberts M, Longo F (1969) Thio-TEPA bladder instillation: therapy and prophylaxis for superficial bladder tumors. J Urol 101:711
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Matsumura, Y., Ozaki, Y., Ohmori, H. et al. Intravesical Adriamycin chemotherapy in bladder cancer. Cancer Chemother. Pharmacol. 11 (Suppl 1), S69–S73 (1983). https://doi.org/10.1007/BF00256723
Issue Date:
DOI: https://doi.org/10.1007/BF00256723